DW-1029M

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDW-1029M
Drug Alias NameDW-1029M
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsAdvanced glycation end product inhibitors
TargetsTransforming growth factor beta 1Advanced glycation end product
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong Wha Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDong Wha Pharm Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A